Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia.
Elisavet ChartomatsidouStavroula NtoufaKonstantia KottaAlessandra RovidaMaria Anna AkritidouDaniela BelloniElisabetta FerreroTheoni TrangasNiki StavroyianniAchilles AnagnostopoulosRichard RosenquistPaolo GhiaNikos PapakonstantinouKostas StamatopoulosPublished in: Blood advances (2020)